Back
Sarepta Therapeutics Vs. Johnson & Johnson Industry Stock Comparison
Buy
60
SRPT
Sarepta Therapeutics
Last Price:
156.70
Seasonality Move:
18.65%
Sell
32
JNJ
Johnson & Johnson
Last Price:
146.42
Seasonality Move:
0.67%
Buy
60
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $156.75. The Score for SRPT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
Johnson & Johnson (JNJ)
is a Sell
Is Johnson & Johnson a Buy, Sell or Hold?
- The current Johnson & Johnson [JNJ] share price is $146.44. The Score for JNJ is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- JNJ is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $156.75
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
JNJ Stock Price Chart
What is Johnson & Johnson's stock price today?
-
The Johnson & Johnson share price today is $146.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JNJ is experiencing slight selling pressure.
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.96 | Buy |
Relative Strength Index (14 RSI): | 67.49 | Buy |
Chaikin Money Flow: | -725627 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
JNJ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.5 | Sell |
Relative Strength Index (14 RSI): | 46.1 | Sell |
Chaikin Money Flow: | -2327628 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (145.35 - 147.67) | Sell |
Bollinger Bands (100): | (146.73 - 157.75) | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 154.44 | Buy |
20-day SMA: | 134.31 | Buy |
50-day SMA: | 130.36 | Buy |
200-day SMA: | 116.02 | Buy |
8-day EMA: | 151.7 | Buy |
20-day EMA: | 140.67 | Buy |
50-day EMA: | 132.57 | Buy |
200-day EMA: | 121.76 | Buy |
JNJ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 147.26 | Sell |
20-day SMA: | 146.75 | Sell |
50-day SMA: | 148.17 | Sell |
200-day SMA: | 154.05 | Sell |
8-day EMA: | 146.69 | Sell |
20-day EMA: | 147.03 | Sell |
50-day EMA: | 148.55 | Sell |
200-day EMA: | 154.08 | Sell |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.
Johnson & Johnson Earnings Growth & JNJ Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.13 per share, an increase this year of $0.62 per share, and an increase next year of $0.36 per share.
Sarepta Therapeutics Technical Analysis
Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Johnson & Johnson Technical Analysis
Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |